• Je něco špatně v tomto záznamu ?

Nanotechnology - new trends in the treatment of brain tumours

P. Krůpa, S. Řehák, D. Diaz-Garcia, S. Filip

. 2014 ; 57 (4) : 142-150.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc15030955

High grade gliomas are some of the deadliest human tumours. Conventional treatments such as surgery, radiotherapy and chemotherapy have only a limited effect. Nowadays, resection is the common treatment of choice and although new approaches, such as perioperative magnetic resonance imaging or fluorescent microscopy have been developed, the survival rate of diagnosed patients is still very low. The inefficacy of conventional methods has led to the development of new strategies and the significant progress of nanotechnology in recent years. These platforms can be used either as novel imaging tools or to improve anticancer drug delivery into tumours while minimizing its distribution and toxicity in healthy tissues. Amongst the new nanotechnology platforms used for delivery into the brain tissue are: polymeric nanoparticles, liposomes, dendrimers, nanoshells, carbon nanotubes, superparamagnetic nanoparticles and nucleic acid based nanoparticles (DNA, RNA interference [RNAi] and antisense oligonucleotides [ASO]). These nanoparticles have been applied in the delivery of small molecular weight drugs as well as macromolecules - proteins, peptides and genes. The unique properties of these nanoparticles, such as surface charge, particle size, composition and ability to modify their surface with tissue recognition ligands and antibodies, improve their biodistribution and pharmacokinetics. All of the above mentioned characteristics make of nanoplatforms a very suitable tool for its use in targeted, personalized medicine, where they could possibly carry large doses of therapeutic agents specifically into malignant cells while avoiding healthy cells. This review poses new possibilities in the large field of nanotechnology with special interest in the treatment of high grade brain tumours.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15030955
003      
CZ-PrNML
005      
20190118100625.0
007      
ta
008      
151001s2014 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2015.79 $2 doi
035    __
$a (PubMed)25938897
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Krůpa, Petr, $d 1987- $7 xx0231389 $u Charles University in Prague, Department of Neurosurgery, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Czech Republic
245    10
$a Nanotechnology - new trends in the treatment of brain tumours / $c P. Krůpa, S. Řehák, D. Diaz-Garcia, S. Filip
520    9_
$a High grade gliomas are some of the deadliest human tumours. Conventional treatments such as surgery, radiotherapy and chemotherapy have only a limited effect. Nowadays, resection is the common treatment of choice and although new approaches, such as perioperative magnetic resonance imaging or fluorescent microscopy have been developed, the survival rate of diagnosed patients is still very low. The inefficacy of conventional methods has led to the development of new strategies and the significant progress of nanotechnology in recent years. These platforms can be used either as novel imaging tools or to improve anticancer drug delivery into tumours while minimizing its distribution and toxicity in healthy tissues. Amongst the new nanotechnology platforms used for delivery into the brain tissue are: polymeric nanoparticles, liposomes, dendrimers, nanoshells, carbon nanotubes, superparamagnetic nanoparticles and nucleic acid based nanoparticles (DNA, RNA interference [RNAi] and antisense oligonucleotides [ASO]). These nanoparticles have been applied in the delivery of small molecular weight drugs as well as macromolecules - proteins, peptides and genes. The unique properties of these nanoparticles, such as surface charge, particle size, composition and ability to modify their surface with tissue recognition ligands and antibodies, improve their biodistribution and pharmacokinetics. All of the above mentioned characteristics make of nanoplatforms a very suitable tool for its use in targeted, personalized medicine, where they could possibly carry large doses of therapeutic agents specifically into malignant cells while avoiding healthy cells. This review poses new possibilities in the large field of nanotechnology with special interest in the treatment of high grade brain tumours.
650    _2
$a antitumorózní látky $x terapeutické užití $7 D000970
650    _2
$a nádory mozku $x terapie $7 D001932
650    _2
$a diagnostické zobrazování $7 D003952
650    _2
$a nosiče léků $7 D004337
650    _2
$a systémy cílené aplikace léků $7 D016503
650    _2
$a genetická terapie $7 D015316
650    _2
$a genetické vektory $7 D005822
650    _2
$a lidé $7 D006801
650    _2
$a nanočástice $x terapeutické užití $7 D053758
650    _2
$a nanotechnologie $x trendy $7 D036103
650    _2
$a nanotrubičky $7 D043942
650    _2
$a transplantace kmenových buněk $7 D033581
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Řehák, Svatopluk $u Charles University in Prague, Department of Neurosurgery, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Czech Republic
700    1_
$a Díaz Garcia, Daniel $u Charles University in Prague, Department of Histology and Embryology, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Czech Republic $7 xx0318858
700    1_
$a Filip, Stanislav, $u Charles University in Prague, Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Czech Republic $d 1961- $7 jn20010309153
773    0_
$w MED00010947 $t Acta medica (Hradec Králové) Universitas Carolina, Facultas Medica Hradec Králové $x 1211-4286 $g Roč. 57, č. 4 (2014), s. 142-150
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/am_2014057040142.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y 4 $z 0
990    __
$a 20151001 $b ABA008
991    __
$a 20190118100840 $b ABA008
999    __
$a ok $b bmc $g 1094790 $s 914071
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 57 $c 4 $d 142-150 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
LZP    __
$b NLK118 $a Pubmed-20151001

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...